Gross Profit (TTM) Chart

View Gross Profit (TTM) for ELTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit (TTM) Chart
Start Trial

Historical Gross Profit (TTM) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -1.141M
March 31, 2026 -1.139M
December 31, 2025 -1.128M
September 30, 2025 -1.147M
June 30, 2025 -1.154M
March 31, 2025 -1.166M
December 31, 2024 -1.178M
September 30, 2024 -1.159M
June 30, 2024 -0.869M
March 31, 2024 -0.576M
December 31, 2023 -0.396M
September 30, 2023 -0.404M
June 30, 2023 -0.504M
March 31, 2023 -0.504M
Date Value
December 31, 2022 1.026M
September 30, 2022 26.60M
June 30, 2022 27.95M
March 31, 2022 28.28M
December 31, 2021 27.08M
September 30, 2021 1.98M
June 30, 2021 1.075M
March 31, 2021 0.967M
December 31, 2020 1.062M
September 30, 2020 1.137M
June 30, 2020 0.799M
March 31, 2020 0.573M
December 31, 2019 0.262M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Precigen, Inc. 76.45M
Agenus, Inc. 127.32M
Amgen, Inc. 27.78B
Anika Therapeutics, Inc. 75.00M
BioCryst Pharmaceuticals, Inc. 917.38M